Klieser E, Lehmann E
Psychiatry Division, University of Düsseldorf-Rheinische Landesklinik, Federal Republic of Germany.
Psychopharmacology (Berl). 1988;95 Suppl:S3-5. doi: 10.1007/BF00172621.
We are performing a double-blind trial with inward psychiatric patients. The indication for our psychotropic or psychotherapeutic intervention is mainly severe depression (= major depressive disorders DSM III). For a 3-week trial course trazodone (400 mg daily), amitriptyline (150 mg/die) or placebo capsules were given at random. All patients received the same type of cognitive behaviour therapy. The test battery consists of CGI, BPRS, HAMD, HAMA and AMDP; adverse drug reactions are documented as "free reports" (= freier Nebenwirkungsbericht). The interim results (until March 1987) will be presented. Our investigation indicates that it is probable that the trazodone treatment we used is equivalent to corresponding amitriptyline treatment.
我们正在对住院精神科患者进行一项双盲试验。我们进行精神药物或心理治疗干预的适应症主要是重度抑郁症(=《精神疾病诊断与统计手册第三版》中的重度抑郁障碍)。在为期3周的试验过程中,随机给予曲唑酮(每日400毫克)、阿米替林(每日150毫克)或安慰剂胶囊。所有患者均接受相同类型的认知行为疗法。测试组包括临床总体印象量表(CGI)、简明精神病评定量表(BPRS)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)和慕尼黑精神症状综合评定量表(AMDP);药物不良反应以“自由报告”(=自发不良反应报告)的形式记录。将公布中期结果(截至1987年3月)。我们的调查表明,我们所使用的曲唑酮治疗可能与相应的阿米替林治疗等效。